News
TEVA
17.81
+1.57%
0.28
Teva presents positive data from Ajovy pediatric study
Seeking Alpha · 10h ago
Noteworthy ETF Inflows: IDEV, TEVA, CHKP, CYBR
NASDAQ · 10h ago
Teva's Phase 3 Study Of AJOVY Shows Superior Efficacy In Migraine Prevention For Children
NASDAQ · 14h ago
Teva Pharmaceuticals Reports Positive Phase 3 Results for AJOVY® (fremanezumab) in Reducing Migraine Days in Pediatric Patients Aged 6-17
Barchart · 15h ago
Teva presents data from SPACE study
TipRanks · 16h ago
Teva Shares Phase 3 SPACE Trial Results Highlighting The Efficacy And Safety Of AJOVY (Fremanezumab) In Preventing Episodic Migraine In Children And Adolescents
Benzinga · 19h ago
TEVA - TRIAL SHOWED STATISTICALLY SIGNIFICANT SUPERIOR EFFICACY OF AJOVY VS PLACEBO OVER 12 WEEKS
Reuters · 19h ago
Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial
Barchart · 1d ago
Is SoundHound AI a Millionaire-Maker Stock?
NASDAQ · 1d ago
Analysts Anticipate CRBN Will Reach $224
NASDAQ · 1d ago
Notable open interest changes for December 2nd
TipRanks · 2d ago
Weekly Report: what happened at TEVA last week (1125-1129)?
Weekly Report · 2d ago
TEVA Stock Down 10% in a Month: Should You Buy the Dip?
Barchart · 6d ago
IEFA, SE, AER, TEVA: Large Inflows Detected at ETF
NASDAQ · 11/26 16:35
Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference
Barchart · 11/25 17:00
Weekly Report: what happened at TEVA last week (1118-1122)?
Weekly Report · 11/25 09:16
Emerging-Markets Stocks Have Rarely Been So Hated. It's Time To Buy
The Wall Street Journal · 11/23 12:00
AbbVie: Upgrading To 'Strong Buy' After Pullback
Seeking Alpha · 11/22 20:10
Goldman’s Hedge Fund VIP List: AMZN, VST, CRM, BABA, and more
Seeking Alpha · 11/20 18:15
Validea Detailed Fundamental Analysis - TEVA
NASDAQ · 11/18 19:00
More
Webull provides a variety of real-time TEVA stock news. You can receive the latest news about Teva Pharm through multiple platforms. This information may help you make smarter investment decisions.
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.